Erythromycin

ADVERTISEMENT

Identification

Molecular formula
C37H67NO13
CAS Number
114-07-8
IUPAC Name
[1-methyl-7-oxo-6-[(3,4,5-trihydroxy-2-methoxy-8-methyl-non-6-enoyl)amino]azepan-3-yl] tetradecanoate
Molecular Weight
733.94g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.1800g/cm3
Interesting facts

Interesting Facts about 1-Methyl-7-oxo-6-[(3,4,5-trihydroxy-2-methoxy-8-methyl-non-6-enoyl)amino]azepan-3-yl] Tetradecanoate

This intriguing compound belongs to a class known as bioactive lipids, showcasing a diverse range of structural characteristics that underline its potential in various applications. Here are some key insights:

  • Complex Structure: The compound features a unique azepan ring, a seven-membered cyclic amine, which contributes to its complex behavior and interactions within biological systems.
  • Functional Groups: The presence of multiple functional groups, including a ketone and amine, enhances its reactivity and potential biological activity, making it a candidate for research in pharmacology.
  • Natural Source: Similar structures are often found in natural products, particularly those derived from plants and marine organisms, suggesting a potential role in therapeutic applications or dietary benefits.
  • Potential Health Benefits: The trihydroxy component hints at antioxidant properties, which could play a significant role in combating oxidative stress in cells.
  • Research Interest: Due to its complex pharmacophore, this compound is an exciting subject for medicinal chemistry, particularly in drug design aimed at targeting specific biological pathways.

As noted by researchers, "The intricate architecture of such compounds often dictates their biological activity, paving the way for novel therapeutic strategies." Thus, studying 1-methyl-7-oxo-6-[(3,4,5-trihydroxy-2-methoxy-8-methyl-non-6-enoyl)amino]azepan-3-yl] tetradecanoate not only reveals the richness of chemical diversity but also highlights the ongoing quest for new medications derived from nature.

ADVERTISEMENT